Product Recalls in Arkansas

Product recalls affecting Arkansas — including food, drugs, consumer products, medical devices, and vehicles distributed to Arkansas. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,662 recalls have been distributed to Arkansas in the last 12 months.

49,990 total recalls
2,662 in last 12 months

Showing 13611380 of 13,434 recalls

DrugOctober 27, 2023· NCS Healthcare of Kentucky Inc

Recalled Item: Buspirone Hydrochloride Tabs USP 10 mg Recalled by NCS Healthcare of...

The Issue: Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 27, 2023· Amneal Pharmaceuticals of New York, LLC

Recalled Item: Extended Phenytoin Sodium Capsules Recalled by Amneal Pharmaceuticals of New...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 26, 2023· VistaPharm LLC

Recalled Item: Mycophenolate Mofetil for Oral Suspension Recalled by VistaPharm LLC Due to...

The Issue: Defective Container: The adaptor does not fit into the neck of the bottle...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 23, 2023· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Phenytoin Oral Suspension Recalled by The Harvard Drug Group LLC dba Major...

The Issue: Failed Content Uniformity Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 23, 2023· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Esomeprazole Magnesium Delayed-Release Capsules Recalled by Glenmark...

The Issue: Failed Impurities/Degradation Specifications:Out of Specification result...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 23, 2023· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Ranolazine Extended-Release Tablets 500mg Recalled by Glenmark...

The Issue: Failed Dissolution Specifications: Out of specification for dissolution.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 20, 2023· Botanical Be

Recalled Item: Artri King con Origa y Omega 3 tablets Recalled by Botanical Be Due to...

The Issue: Marketed Without an Approved NDA/ANDA: products found to contain undeclared...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 20, 2023· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Bisoprolol Fumarate and Hydrochlorothiazide Tablets Recalled by Glenmark...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 20, 2023· Botanical Be

Recalled Item: Reumo Flex caplets Recalled by Botanical Be Due to Undeclared Diclofenac

The Issue: Marketed Without an Approved NDA/ANDA: products found to contain undeclared...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 20, 2023· Botanical Be

Recalled Item: Kuka Flex Forte caplets Recalled by Botanical Be Due to Undeclared Diclofenac

The Issue: Marketed Without an Approved NDA/ANDA: products found to contain undeclared...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 20, 2023· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Deferasirox Tablets for Oral Suspension Recalled by Glenmark Pharmaceuticals...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 20, 2023· Zyla Life Sciences US Inc.

Recalled Item: Oxaydo (oxycodone HCl Recalled by Zyla Life Sciences US Inc. Due to...

The Issue: Sub-potent Drug: Lower potency than labeled.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 20, 2023· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Liothyronine Sodium Tablets Recalled by SUN PHARMACEUTICAL INDUSTRIES INC...

The Issue: Failed Impurities/Degradation Specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 20, 2023· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Liothyronine Sodium Tablets Recalled by SUN PHARMACEUTICAL INDUSTRIES INC...

The Issue: Failed Impurities/Degradation Specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 20, 2023· Edenbridge Pharmaceuticals, LLC

Recalled Item: Opium Tincture Recalled by Edenbridge Pharmaceuticals, LLC Due to Subpotent Drug

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 19, 2023· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Oxybutynin Chloride Extended-Release Tablet USP Recalled by Zydus...

The Issue: Failed Dissolution Specifications-out-of-specification (OOS) test results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 19, 2023· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Oxybutynin Chloride Extended-Release Tablet USP Recalled by Zydus...

The Issue: Failed Dissolution Specifications-out-of-specification (OOS) test results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 19, 2023· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Oxybutynin Chloride Extended-Release Tablet USP Recalled by Zydus...

The Issue: Failed Dissolution Specifications-out-of-specification (OOS) test results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 19, 2023· Safecor Health, LLC

Recalled Item: Strong Iodine Solution U.S.P. (Lugol's Solution) (Iodine 5%) Recalled by...

The Issue: CGMP Deviations: Recall due to the absence of USP CGMP compendial requirements.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 18, 2023· Exela Pharma Sciences LLC

Recalled Item: ELCYS (cysteine hydrochloride injection) Recalled by Exela Pharma Sciences...

The Issue: Presence of Particulate Matter: Silicone

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund